1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[4-(methylsulfonyl)-5-thiazolyl]thio]-7-oxo-, monosodium salt, (4R,5S,6S)-
738617-75-9
4-Morpholinecarboxylic acid,5-[(1S,2S)-2-(acetylamino)-3-(3,5-difluorophenyl)-1-hydroxypropyl]-2-[[1-(phenylmethyl)cyclohexyl]methoxy]-, 1,1-dimethylethyl ester, (2R,5R)-
883440-36-6
13-Docosenamide, N-(4-methoxyphenyl)-, (13Z)-
873549-90-7
1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[1-[4-[[(phenylsulfonyl)amino]methyl]-2-oxazolyl]-3-azetidinyl]thio]-, (4R,5S,6S)-
429673-67-6
1,8-Naphthyridine-3-carboxylic acid,7-(3-amino-1-pyrrolidinyl)-1,4-dihydro-4-oxo-
635306-68-2
1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[1-[4-[(4-methyl-1-piperazinyl)carbonyl]-2-thiazolyl]-3-azetidinyl]thio]-7-oxo-, (4-nitrophenyl)methyl ester,(4R,5S,6S)-
3-Amino-2,2-dimethylpropanamide hydrochloride
1-Azabicyclo[2.2.2]octane, 3-[[6-(1H-indol-3-yl)-3-pyridazinyl]oxy]-,(2E)-2-butenedioate (2:1)
1,8-Naphthyridine-3-carboxylic acid,6-fluoro-1,4-dihydro-7-[3-[(1-methyl-1-phenylethyl)amino]-1-pyrrolidinyl]-4-oxo-, mono(trifluoroacetate)